Ultrasound guided core biopsy demonstrated a grade 2, hormone positive [ER+ve 280/300, PR+ve 300/300], HER2-ve invasive ductal carcinoma with no ductal carcinoma in situ (DCIS). This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.